Viewing Study NCT07465120


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 11:42 AM
Study NCT ID: NCT07465120
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-11
First Post: 2026-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis
Sponsor: Dermavon Holdings Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module